Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Brazilian (BOVESPA) Drug Retail Industry Analysis

UpdatedNov 18, 2024
DataAggregated Company Financials
Companies4
  • 7D-0.2%
  • 3M-12.2%
  • 1Y-7.5%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 1.0%, driven by declines from every company within the industry. Overall the industry is down 9.1% in 12 months. Looking forward, earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Brazilian Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 19 Nov 2024R$47.2bR$56.7bR$1.4b12.6x33.6x0.8x
Thu, 17 Oct 2024R$47.4bR$54.8bR$1.3b17.2x37.9x0.9x
Sat, 14 Sep 2024R$49.4bR$54.8bR$1.3b17.5x39.4x0.9x
Mon, 12 Aug 2024R$54.1bR$54.6bR$1.3b17x42.7x1x
Wed, 10 Jul 2024R$46.6bR$53.1bR$1.2b28.5x38.5x0.9x
Fri, 07 Jun 2024R$46.4bR$53.1bR$1.2b27.9x38.4x0.9x
Sun, 05 May 2024R$48.7bR$51.4bR$1.2b30.5x41.7x0.9x
Tue, 02 Apr 2024R$49.6bR$51.4bR$1.2b31.2x42.4x1x
Thu, 29 Feb 2024R$49.3bR$49.8bR$1.1b19.9x46.5x1x
Sat, 27 Jan 2024R$48.6bR$49.8bR$1.1b20.6x45.9x1x
Mon, 25 Dec 2023R$53.6bR$49.8bR$1.1b22.1x50.7x1.1x
Wed, 22 Nov 2023R$53.0bR$49.9bR$1.1b20.2x50.1x1.1x
Fri, 20 Oct 2023R$48.3bR$48.1bR$948.8m19.6x51x1x
Sun, 17 Sep 2023R$51.2bR$48.1bR$948.8m22.4x53.9x1.1x
Tue, 15 Aug 2023R$51.1bR$47.4bR$1.0b24.2x49.2x1.1x
Thu, 13 Jul 2023R$52.6bR$46.0bR$1.1b23.2x49.6x1.1x
Sat, 10 Jun 2023R$52.8bR$46.0bR$1.1b21.9x49.8x1.1x
Mon, 08 May 2023R$46.9bR$45.1bR$1.1b18.1x40.9x1x
Wed, 05 Apr 2023R$43.3bR$43.7bR$1.1b16.7x39.6x1x
Fri, 03 Mar 2023R$40.0bR$41.4bR$1.0b29.3x39.5x1x
Sun, 29 Jan 2023R$45.2bR$41.4bR$1.0b32.5x44.8x1.1x
Tue, 27 Dec 2022R$42.7bR$41.4bR$1.0b31.4x42.3x1x
Thu, 24 Nov 2022R$40.8bR$41.4bR$1.0b30.3x40.4x1x
Sat, 22 Oct 2022R$44.4bR$39.2bR$1.0b21.7x42.3x1.1x
Mon, 19 Sep 2022R$41.3bR$39.2bR$1.0b19.5x39.4x1.1x
Wed, 17 Aug 2022R$41.7bR$39.2bR$1.0b21.2x39.7x1.1x
Fri, 15 Jul 2022R$37.6bR$37.4bR$945.0m33.1x39.8x1x
Sun, 12 Jun 2022R$38.5bR$37.4bR$945.0m33.4x40.7x1x
Tue, 10 May 2022R$36.0bR$37.2bR$944.3m32x38.1x1x
Thu, 07 Apr 2022R$45.3bR$36.0bR$997.8m38.8x45.4x1.3x
Sat, 05 Mar 2022R$46.0bR$35.8bR$1.0b32.9x45.2x1.3x
Mon, 31 Jan 2022R$43.0bR$34.8bR$1.0b31.8x42.7x1.2x
Wed, 29 Dec 2021R$45.6bR$34.8bR$1.0b34.2x45.3x1.3x
Fri, 26 Nov 2021R$44.6bR$34.8bR$1.0b36.3x44.2x1.3x
Price to Earnings Ratio

44.2x


Total Market Cap: R$44.6bTotal Earnings: R$1.0bTotal Revenue: R$34.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Drug Retail Industry Price to Earnings3Y Average 43.2x202220232024
Current Industry PE
  • Investors are pessimistic on the Brazilian Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 34.3x which is lower than its 3-year average PE of 43.3x.
  • The 3-year average PS ratio of 1.0x is higher than the industry's current PS ratio of 0.84x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have grown 11% per year over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Brazilian Drug Retail compare with similar industries?

BR Market-0.062%
Consumer Staples1.63%
Food and Staples Retail-1.24%
Drug Retail-0.21%
Food Distributors0%
Big Box Super Stores-2.32%
Food Retail-4.44%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RADL3 Raia DrogasilR$25.690.9%
+R$394.5m		-10.2%PE39.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PNVL3

R$9.70

Dimed Distribuidora de Medicamentos

7D

-2.7%

1Y

-18.9%

Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Nov 17
Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

PGMN3

R$3.17

Empreendimentos Pague Menos

7D

-2.8%

1Y

-13.4%

We Think You Should Be Aware Of Some Concerning Factors In Empreendimentos Pague Menos' (BVMF:PGMN3) Earnings

Nov 12
We Think You Should Be Aware Of Some Concerning Factors In Empreendimentos Pague Menos' (BVMF:PGMN3) Earnings

RADL3

R$25.69

Raia Drogasil

7D

0.9%

1Y

-10.2%

Earnings Beat: Raia Drogasil S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 08
Earnings Beat: Raia Drogasil S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

DMVF3

R$6.38

d1000 Varejo Farma Participações

7D

-6.3%

1Y

27.9%